GLP1-RAs may improve psychiatric outcomes in obesity & diabetes. Meta-analysis of 14 trials: enhanced QOL & cognition. PMID:40366681, JAMA Psychiatry 2025, @JAMAPsych https://doi.org/10.1001/jamapsychiatry.2025.0679 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
https://doi.org/10.1001/jamapsychiatry.2025.0679
No description available
doi.org